Dimensional Fund Advisors
DAWN

Dimensional Fund Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History

Dimensional Fund Advisors’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6M Sell
819,371
-217,941
-21% -$3.07M ﹤0.01% 2033
2025
Q4 		$9.67M Sell
1,037,312
-185,972
-15% -$1.55M ﹤0.01% 2295
2025
Q3 		$8.62M Sell
1,223,284
-193,269
-14% -$1.33M ﹤0.01% 2357
2025
Q2 		$9.21M Buy
1,416,553
+113,588
+9% +$781K ﹤0.01% 2308
2025
Q1 		$10.3M Buy
1,302,965
+375,948
+41% +$4.05M ﹤0.01% 2240
2024
Q4 		$11.7M Buy
927,017
+90,822
+11% +$1.26M ﹤0.01% 2244
2024
Q3 		$11.6M Sell
836,195
-51,922
-6% -$741K ﹤0.01% 2238
2024
Q2 		$12.2M Sell
888,117
-93,455
-10% -$1.37M ﹤0.01% 2174
2024
Q1 		$16.2M Buy
981,572
+203,655
+26% +$3.05M ﹤0.01% 2089
2023
Q4 		$11.4M Buy
777,917
+471,732
+154% +$5.72M ﹤0.01% 2264
2023
Q3 		$3.76M Buy
306,185
+123,007
+67% +$1.6M ﹤0.01% 2615
2023
Q2 		$2.19M Sell
183,178
-180,881
-50% -$2.36M ﹤0.01% 2756
2023
Q1 		$4.87M Buy
364,059
+225,451
+163% +$4.4M ﹤0.01% 2495
2022
Q4 		$2.98K Buy
138,608
+87,200
+170% +$1.79M ﹤0.01% 2601
2022
Q3 		$1.03M Buy
+51,408
New +$1.09M ﹤0.01% 2873

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Dimensional Fund Advisors's DAWN Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Day One Biopharmaceuticals (DAWN) stake by 21% in Q1 2026, selling an estimated $3.07M and leaving 819,371 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

Dimensional Fund Advisors first reported a position in DAWN in Q3 2022 and has held it in 15 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Dimensional Fund Advisors held 819,371 shares of Day One Biopharmaceuticals worth $17.6M as of Q1 2026.
  • Dimensional Fund Advisors sold 217,941 Day One Biopharmaceuticals shares in Q1 2026, an estimated $3.07M.
  • Day One Biopharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2033 holding.
  • Dimensional Fund Advisors first reported a position in Day One Biopharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.